You are here

Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose)

Last updated on February 23, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Roma, , 00161 Italy
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Rheumatoid Arthritis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

1. Eighteen years of age or older

2. Diagnosis of RA in accordance with ARA 1987 classification has satisfied at least 4 of
the following 7 criteria:

1. Morning stiffness in and around the joints lasting at least 1 hour;

2. Arthritis of 3 or more joint areas;

3. Arthritis of hand joints;

4. Symmetric arthritis. simultaneous involvement of the same joint areas on both
sides of the body;

5. Rheumatoid nodules;

6. Serum Rheumatoid Factor (RF)

7. Radiographic changes. Criteria 1 through 4 must have been present for at least 6
weeks.

3. Patients refractory or without complete response to DMARDs according to the Italian
Guidelines for the clinical practice established by Italian Society of Rheumatology

4. Patients naive to anti-TNF drugs

5. Outpatients

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

Patients involved in controlled or interventional trials in the 12 previous months

NCT00794118
Pfizer
Completed
Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose)

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Rheumatoid Arthritis
NCT00768053
All Genders
18+
Years
Multiple Sites
Juvenile Rheumatoid Arthritis
NCT00652925
All Genders
2+
Years
Multiple Sites
Rheumatoid Arthritis, Inflammation
NCT00195364
All Genders
18+
Years
Madrid,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now